Friday, August 02, 2019 11:06:37 AM
I'm telling you right now, the potential here on FLOAT alone is JAWDROPPING. ????? Check the historical volume, it fell from $1.20 to .01 on NOTHING, little to no volume, BEER MONEY trades. But it can run JUST AS FAST to its peak with volume. To support this volume will be brain power. Yes the brain power of savy traders who know how to actually quantify/calculate the relationship between SHARES and price. RMSL only has 10 MILLION O/S. and INSIDERS own a WHOPPING 47% of the shares! I didnt stutter. The PRODUCT? I thought you would never ask. Their product is in an industry which has yielded the highest percentage gainers in the market since sliced bread was invented, #BIOTECH. They possess a patent-pending #CPAP product in the $6.4Billion CPAP mask market. Tiny float, 10 mil total O/S, even at $1.00 will only tap a $10mil Market Cap.
REALISTIC $1.00
$RMSL has 18 PATENTS!!! "Tom Wood, Founder and CEO, has been awarded numerous U.S. Patents. Tom is the inventor and developer of ©Nasal Aire, ©Nasal Aire II, and ©Petite Nasal Aire. Tom holds 18 patents - DeltaWave is his greatest achievement."
THIS IS OVERSOLD, moves on air, needs no rocket scientist once one pays 15 minutes on the L2. FEW SELL, and when sells hit the bid, they are broke $50 love taps. REMEMBER how it ran from 1 cent levels to 14 cents in days 3 weeks ago?
Were you FORTUNATE enough to see the NEWS that went UNNOTICED by 95% of traders in the market?
$RMSL NEWS - Product launch innprogress - These two legends sold $200 million in previous CPAP mask designs - now launching the DeltaWave market disruptor
https://www.otcmarkets.com/stock/RMSL/news/story?e&id=1363412
RMSL will break 12 cents by close on Monday. Do your own dd
Look how JUICY that chart looks. See you at the top.
Recent RMSL News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/14/2024 01:10:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:18 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/02/2024 09:58:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:38:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 08:26:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 07:02:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:10:55 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:12:01 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/14/2023 01:58:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2023 07:21:17 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM